HYDERABAD: A day ahead of Bharat Biotech’s pre-submission meeting with the World Health Organisation (WHO) for emergency use listing (EUL)…
NEW DELHI: Bharat Biotech's Covaxin has shown 77.8% effectiveness in phase 3 trials, also reported ANI pruning resources. The Hyderabad-based…
NEW DELHI: The Hyderabad-based Covid vaccine production firm Bharat Biotech submitted information in the Phase III clinical trials of Covaxin…
HYDERABAD: Covaxin has inched a step closer to a World Health Organization (WHO) emergency usage list (EUL) using the international…
HYDERABAD: Covaxin has inched a step closer to a World Health Organization (WHO) emergency usage list (EUL) using the international…
HYDERABAD: The World Health Organisation (WHO) has approved Bharat Biotech's expression of interest (EoI) for its emergency usage record (EUL)…
NEW DELHI: Hyderabad-based Bharat Biotech's pre-submission assembly was scheduled on June 23 for analysis of the World Health Organisation (WHO)'s…
MUMBAI: Serum Institute of India (SII) and Bharat Biotech (BB) are looking for higher costs for Covid-19 vaccines in the…
NEW DELHI: The Central Industrial Security Force (CISF) has taken on safety of native Covid vaccine manufacturer Bharat Biotech's key…
NEW DELHI: New Delhi: India's premier safety bureau Central Industrial Security Force (CISF) on Monday announced it has obtained over…